The diagnostic and prognostic value of cell division cycle associated gene family in Hepatocellular Carcinoma

Cell division cycle associated (CDCA) gene family plays an important role in cells. However, some researchers revealed that overexpression of CDCAs might contribute to the tumor progression in several cancers. Here, we analyzed the role of this gene family in hepatocellular carcinoma (HCC). We used...

Full description

Saved in:
Bibliographic Details
Published in:Journal of Cancer Vol. 11; no. 19; pp. 5727 - 5737
Main Authors: Wu, Bowen, Huang, Yu, Luo, Yingwan, Ma, An, Wu, Zhaoxing, Gan, Yichao, Xu, Ying, Xu, Rongzhen
Format: Journal Article
Language:English
Published: Wyoming Ivyspring International Publisher Pty Ltd 01-01-2020
Ivyspring International Publisher
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Cell division cycle associated (CDCA) gene family plays an important role in cells. However, some researchers revealed that overexpression of CDCAs might contribute to the tumor progression in several cancers. Here, we analyzed the role of this gene family in hepatocellular carcinoma (HCC). We used several web tools and found that most of CDCAs were highly expressed in tumor tissues compared to the paracancer tissues in HCC. We then used RT-qPCR to confirm our results. The results showed that CDCA2, CDCA3, CDCA5 and CDCA8 were up-regulated in HCC. We also found that these genes were associated with poor overall survival and relapse free survival except CDCA7. The functional analysis showed that this gene family might take part in many processes, including cell division, apoptosis, DNA damage and DNA repair, which might contribute to the tumor progression. The KEGG pathway analysis showed that these genes participated in several important pathways such as PI3K-Akt signaling pathway and hippo signaling pathway. In conclusion, our findings suggested that CDCA2, CDCA3, CDCA4, CDCA5, and CDCA8 might have potential diagnostic and prognostic values for hepatocellular carcinoma.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Competing Interests: The authors have declared that no competing interest exists.
These authors contribute equally to this work.
ISSN:1837-9664
1837-9664
DOI:10.7150/jca.46554